1-1 of 1
Elaina M. Gartner, MD
Close
Sort by
Journal Articles

Gemtuzumab Ozogamicin (Mylotarg R ) as Primary Induction Therapy for Elderly Patients with Acute Myeloid Leukemia: A Phase II Trial.

Lisa A. Kujawski, MD, Elaina M. Gartner, MD, Irene Ryan, PA-C, Kent Griffith, Harry P. Erba, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 4508.
https://doi.org/10.1182/blood.V104.11.4508.4508
Published: 2004